Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ (5,607)	$ (679)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	7,852	8,033
Equity-based compensation expense	5,923	4,451
Bad debt expense	1,314	1,614
Deferred income tax expense (benefit)	(202)	(1,579)
Fair value adjustments to contingent consideration	34	(4)
Loss (gain) on sale or disposition of assets, net		178
Non-cash lease benefit	(705)	(766)
Non-cash debt charges	215	212
Other, net	(5)	(116)
Changes in operating assets and liabilities	562	(8,280)
Net cash provided by operating activities	9,381	3,064
Cash flows from investing activities:
Purchases of property, equipment and capitalization of software	(2,619)	(1,489)
Other	189	195
Net cash used in investing activities	(2,430)	(1,294)
Cash flows from financing activities:
Payments on debt	(1,150)	(1,150)
Distributions paid to non-controlling unitholders		(2,889)
Dividends and dividend equivalents paid to Class A common stockholders	(585)	(4,824)
Payments related to tax withholding for share-based compensation	(2,498)	(3,458)
Common shares repurchased		(3,408)
Payment of contingent consideration	(120)	(120)
Net cash used in financing activities	(4,353)	(15,849)
Effect of exchange rate changes on cash	(925)	34
Net increase (decrease) in cash, cash equivalents and restricted cash	1,673	(14,045)
Cash, cash equivalents and restricted cash, beginning of period	125,763	138,128
Cash, cash equivalents and restricted cash, end of period	$ 127,436	$ 124,083